Finoriq research workspace
Aardvark Therapeutics, Inc. (AARD) Historical Metrics
Review reported fundamentals, derived ratios, grouped financial metrics, and historical charts for Aardvark Therapeutics, Inc. (AARD).
Company Snapshot
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- Company
- Aardvark Therapeutics, Inc. (AARD)
- Ticker
- AARD
- Market Cap
- $120.9M
- Latest Price
- $5.525
- Industry
- Biotech & Pharma
Aardvark Therapeutics, Inc. (AARD) Current Valuation Metrics
Static valuation preview for Aardvark Therapeutics, Inc. (AARD). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| Earnings YieldLatest TTM net income divided by market cap. | -63.9% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -56.3% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 1.26x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.